FPHAX Fidelity® Select Pharmaceuticals Port Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Gilead Sciences (NASDAQ:GILD).

The investment seeks capital appreciation. The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

The average market capitalization across the Fidelity® Select Pharmaceuticals Port MF is 182.21B. The market cap for tickers in the group ranges from 14.98B to 419.89B. LLY holds the highest valuation in this group at 419.89B. The lowest valued company is RPRX at 14.98B.

The average weekly volume growth across all stocks in the Fidelity® Select Pharmaceuticals Port MF was 6%. For the same stocks of the MF, the average monthly volume growth was -14% and the average quarterly volume growth was 12%